Keros Therapeutics
KROS
KROS
151 hedge funds and large institutions have $558M invested in Keros Therapeutics in 2025 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 41 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 138 → 151 (+13)
1.61% less ownership
Funds ownership: 88.46% → 86.86% (-1.6%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
151
Holding in Top 10
3
Calls
$10.1M
Puts
$7.49M
Top Buyers
| 1 | +$10.4M | |
| 2 | +$6.99M | |
| 3 | +$4.18M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$3.07M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$2.47M |
Top Sellers
| 1 | -$18.2M | |
| 2 | -$7.65M | |
| 3 | -$6.31M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$6.13M |
| 5 |
NM
Newtyn Management
New York
|
-$3.3M |
